Myeloid neoplasms with MYC-positive double minutes: towards recognition as a distinct entity
Open Access
- 3 March 2025
- journal article
- Published by Springer Nature in Blood Cancer Journal
- Vol. 15 (1) , 29
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Interplay of TP53 allelic state, blast count, and complex karyotype on survival of patients with AML and MDSBlood Advances, 2023
- AML classification in the year 2023: How to avoid a Babylonian confusion of languagesLeukemia, 2023
- The diverse landscape of fusion transcripts in 25 different hematological entitiesLeukemia & Lymphoma, 2021
- Genomic amplification of MYC as double minutes in a patient with APL-like leukemiaMolecular Cytogenetics, 2014
- Rapid response to induction in a case of acute promyelocytic leukemia with MYC amplification on double minutes at diagnosisCancer Genetics and Cytogenetics, 2010
- Concomitant and successive amplifications of MYC in APL-like leukemiaCancer Genetics and Cytogenetics, 2010
- Deletion of MYC and presence of double minutes with MYC amplification in a morphologic acute promyelocytic leukemia–like case lacking RARA rearrangement: could early exclusion of double-minute chromosomes be a prognostic factor?Cancer Genetics and Cytogenetics, 2006
- MYC-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of MYC as the target geneHuman Molecular Genetics, 2006
- Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 casesLeukemia, 2002
- Molecular biology of double‐minute chromosomesBioEssays, 1993